Home > Analytics > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Intrinsic Value | Fundamental Analysis

BOM : 500126     NSE : PGHL    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Jun 10,2026
Price(EOD): ₹ 6,256.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 10,385.54 Cr
Value of ₹ 1 Lac invested in PROCTER & GAMBLE HEALTH
on Jun 10,2021 (price: ₹ 5,834.75)

₹ 1 L

₹ 1.07 L

1W : 0.9% 1M : 18.7% 1Y : 11%
COMMUNITY POLL
for PROCTER & GAMBLE HEALTH
Please provide your vote to see the results
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
PROCTER & GAMBLE HEALTH 0.9% 18.7% 11%
SUN PHARMACEUTICAL INDUSTRIES 0.4% -4.6% 6.9%
DIVIS LABORATORIES 0.7% -1.1% 2.1%
TORRENT PHARMACEUTICALS 2.9% -1.2% 42.7%
CIPLA -1.5% 5.5% -6.5%
DR REDDYS LABORATORIES 0.4% -0.6% 1.3%
MANKIND PHARMA 0.7% -4% 1.9%
LUPIN NA 0.1% 16.5%
ZYDUS LIFESCIENCES 1.2% 14.8% 18.7%

FUNDAMENTAL ANALYSIS OF PROCTER & GAMBLE HEALTH

 
Fundamentals Score
[ Q(TTM): Mar2026, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 PGHL is one of the top 24% companies with good fundamentals ! Discover More →


VALUATION OF PROCTER & GAMBLE HEALTH

 
Valuation Score
[As on : Jun 10,2026 ]

Ratio Standalone
P/E
P/B
P/S
31.77
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 326.91 Cr
[Latest Qtr - Mar2026 - Standalone Results ]

19.8
P/B Calculated based on Book Value of Rs 524.55 Cr
[Latest Year - Mar2026 - Standalone Results ]

7.38
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2026 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 28% undervalued companies ! Discover More →

FAIR VALUE OF PROCTER & GAMBLE HEALTH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
22%
41%
34%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF PROCTER & GAMBLE HEALTH


Insights 💡 PGHL is one of the top 20% companies with bullish price momentum currently! Discover More →

PROCTER & GAMBLE HEALTH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF PROCTER & GAMBLE HEALTH

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF PROCTER & GAMBLE HEALTH

Pledged Promoter Shares
0 %
As on : Mar2026

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF PROCTER & GAMBLE HEALTH

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-0.91%
22.75%
22.41%
21.92%
19.12%
67.56%
69.63%
54.63%
QtrlyTrend
6
Latest Qtr: Mar2026
Quarterly Result Analysis →


PROCTER & GAMBLE HEALTH related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 1% 1% 10.4%
BSE 1000 -0.9% -3.8% -2.2%
No NSE index found

You may also like the below Video Courses


FAQ about PROCTER & GAMBLE HEALTH


Is PROCTER & GAMBLE HEALTH good for long term investment?

As on Jun 10,2026, the Fundamentals of PROCTER & GAMBLE HEALTH look Strong and hence it may be good for long term investment! See Financial Performance of PROCTER & GAMBLE HEALTH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is PROCTER & GAMBLE HEALTH UnderValued or OverValued?

As on Jun 10,2026, PROCTER & GAMBLE HEALTH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of PROCTER & GAMBLE HEALTH ?

As on Jun 10,2026, the Intrinsic Value of PROCTER & GAMBLE HEALTH is Rs. 4,676.31 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 5,113.11
Fair Value [Median EV / Sales Model] : Rs. 4,422.61
Fair Value [Median Price / Sales Model] : Rs. 4,676.31
Estimated Median Fair Value of PROCTER & GAMBLE HEALTH : Rs. 4,676.31

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is PROCTER & GAMBLE HEALTH trading at a Premium or Discount?

As on Jun 10,2026, PROCTER & GAMBLE HEALTH is trading at a Premium of 34% based on the estimates of Median Intrinsic Value!